Northcott, P. A. et al. Medulloblastoma. Nat. Rev. Dis. Primers 5, 11 (2019).
Hovestadt, V. et al. Medulloblastomics revisited: organic and medical insights from hundreds of sufferers. Nat. Rev. Most cancers 20, 42–56 (2020).
Haldipur, P., Millen, Okay. J. & Aldinger, Okay. A. Human cerebellar growth and transcriptomics: implications for neurodevelopmental issues. Annu. Rev. Neurosci. 45, 515–531 (2022).
Jones, D. T. W. et al. Molecular traits and therapeutic vulnerabilities throughout paediatric stable tumours. Nat. Rev. Most cancers 19, 420–438 (2019).
Hovestadt, V. et al. Resolving medulloblastoma mobile structure by single-cell genomics. Nature 572, 74–79 (2019).
Vladoiu, M. C. et al. Childhood cerebellar tumours mirror conserved fetal transcriptional applications. Nature 572, 67–73 (2019).
Haldipur, P. et al. Spatiotemporal growth of major progenitor zones within the creating human cerebellum. Science 366, 454–460 (2019).
Aldinger, Okay. A. et al. Spatial and cell sort transcriptional panorama of human cerebellar growth. Nat. Neurosci. 24, 1163–1175 (2021).
Jessa, S. et al. Stalled developmental applications on the root of pediatric mind tumors. Nat. Genet. 51, 1702–1713 (2019).
Gibson, P. et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 468, 1095–1099 (2010).
Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469–474 (2018).
Consalez, G. G., Goldowitz, D., Casoni, F. & Hawkes, R. Origins, growth, and compartmentation of the granule cells of the cerebellum. Entrance. Neural Circuits 14, 611841 (2020).
Cao, J. et al. A human cell atlas of fetal gene expression. Science 370, eaba7721 (2020).
Englund, C. et al. Unipolar brush cells of the cerebellum are produced within the rhombic lip and migrate via creating white matter. J. Neurosci. 26, 9184–9195 (2006).
Hagan, N. & Zervas, M. Wnt1 expression temporally allocates higher rhombic lip progenitors and defines their terminal cell destiny within the cerebellum. Mol. Cell. Neurosci. 49, 217–229 (2012).
McDonough, A. et al. Unipolar (dendritic) brush cells are morphologically advanced and require Tbr2 for differentiation and migration. Entrance. Neurosci. 14, 598548 (2020).
Furukawa, T., Morrow, E. M. & Cepko, C. L. Crx, a novel otx-like homeobox gene, reveals photoreceptor-specific expression and regulates photoreceptor differentiation. Cell 91, 531–541 (1997).
Kozareva, V. et al. A transcriptomic atlas of mouse cerebellar cortex comprehensively defines cell varieties. Nature 598, 214–219 (2021).
Nayler, S., Agarwal, D., Curion, F., Bowden, R. & Becker, E. B. E. Excessive-resolution transcriptional panorama of xeno-free human induced pluripotent stem cell-derived cerebellar organoids. Sci. Rep. 11, 12959 (2021).
Cho, Y. J. et al. Integrative genomic evaluation of medulloblastoma identifies a molecular subgroup that drives poor medical end result. J. Clin. Oncol. 29, 1424–1430 (2011).
Garancher, A. et al. NRL and CRX outline photoreceptor id and reveal subgroup-specific dependencies in medulloblastoma. Most cancers Cell 33, 435–449 (2018).
Kool, M. et al. Built-in genomics identifies 5 medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological options. PLoS One 3, e3088 (2008).
Northcott, P. A. et al. Medulloblastoma includes 4 distinct molecular variants. J. Clin. Oncol. 29, 1408–1414 (2011).
Northcott, P. A. et al. The entire-genome panorama of medulloblastoma subtypes. Nature 547, 311–317 (2017).
Sharma, T. et al. Second-generation molecular subgrouping of medulloblastoma: a world meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol. 138, 309–326 (2019).
Lin, C. Y. et al. Lively medulloblastoma enhancers reveal subgroup-specific mobile origins. Nature 530, 57–62 (2016).
Bunt, J. et al. OTX2 straight prompts cell cycle genes and inhibits differentiation in medulloblastoma cells. Int. J. Most cancers 131, E21–E32 (2012).
Candy-Cordero, E. A. & Biegel, J. A. The genomic panorama of pediatric cancers: implications for analysis and therapy. Science 363, 1170–1175 (2019).
Grobner, S. N. et al. The panorama of genomic alterations throughout childhood cancers. Nature 555, 321–327 (2018).
Northcott, P. A. et al. Enhancer hijacking prompts GFI1 household oncogenes in medulloblastoma. Nature 511, 428–434 (2014).
Goodrich, L. V., Milenkovic, L., Higgins, Okay. M. & Scott, M. P. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109–1113 (1997).
Kawauchi, D. et al. A mouse mannequin of probably the most aggressive subgroup of human medulloblastoma. Most cancers Cell 21, 168–180 (2012).
Pei, Y. et al. An animal mannequin of MYC-driven medulloblastoma. Most cancers Cell 21, 155–167 (2012).
Swartling, F. J. et al. Distinct neural stem cell populations give rise to disparate mind tumors in response to N-MYC. Most cancers Cell 21, 601–613 (2012).
Perreault, S. et al. MRI surrogates for molecular subgroups of medulloblastoma. Am. J. Neuroradiol. 35, 1263–1269 (2014).
Wefers, A. Okay. et al. Subgroup-specific localization of human medulloblastoma based mostly on pre-operative MRI. Acta Neuropathol. 127, 931–933 (2014).
Gajjar, A. et al. Outcomes by medical and molecular options in youngsters with medulloblastoma handled with risk-adapted remedy: outcomes of a world section III trial (SJMB03). J. Clin. Oncol. 39, 822–835 (2021).
Robinson, G. W. et al. Threat-adapted remedy for younger youngsters with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, section 2 trial. Lancet Oncol. 19, 768–784 (2018).
Patay, Z. et al. MR imaging traits of Wingless-type-subgroup pediatric medulloblastoma. Am. J. Neuroradiol. 36, 2386–2393 (2015).
Aldape, Okay. et al. Challenges to curing major mind tumours. Nat. Rev. Clin. Oncol. 16, 509–520 (2019).
Gajjar, A. J. & Robinson, G. W. Medulloblastoma—translating discoveries from the bench to the bedside. Nat. Rev. Clin. Oncol. 11, 714–722 (2014).
Cavalli, F. M. G. et al. Intertumoral heterogeneity inside medulloblastoma subgroups. Most cancers Cell 31, 737–754 (2017).
Poli, V. et al. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state. Nat. Commun. 9, 1024 (2018).
Friedmann-Morvinski, D. et al. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science 338, 1080–1084 (2012).
Morfouace, M. et al. Pemetrexed and gemcitabine as mixture remedy for the therapy of Group 3 medulloblastoma. Most cancers Cell 25, 516–529 (2014).
Pei, Y. et al. HDAC and PI3K antagonists cooperate to inhibit development of MYC-driven medulloblastoma. Most cancers Cell 29, 311–323 (2016).
Tao, R. et al. MYC drives group 3 medulloblastoma via transformation of Sox2+ astrocyte progenitor cells. Most cancers Res. 79, 1967–1980 (2019).
Kawauchi, D. et al. Novel MYC-driven medulloblastoma fashions from a number of embryonic cerebellar cells. Oncogene 36, 5231–5242 (2017).
Behesti, H., Kocabas, A., Buchholz, D. E., Carroll, T. S. & Hatten, M. E. Altered temporal sequence of transcriptional regulators within the era of human cerebellar granule cells. eLife 10, e67074 (2021).
Polanski, Okay. et al. BBKNN: quick batch alignment of single cell transcriptomes. Bioinformatics 36, 964–965 (2020).
La Manno, G. et al. RNA velocity of single cells. Nature 560, 494–498 (2018).
Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states via dynamical modeling. Nat. Biotechnol. 38, 1408–1414 (2020).
Stuart, T. et al. Complete integration of single-cell knowledge. Cell 177, 1888–1902 (2019).
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression knowledge evaluation. Genome Biol. 19, 15 (2018).
Wang, X., Park, J., Susztak, Okay., Zhang, N. R. & Li, M. Bulk tissue cell sort deconvolution with multi-subject single-cell expression reference. Nat. Commun. 10, 380 (2019).
Subramanian, A. et al. Gene set enrichment evaluation: a knowledge-based strategy for deciphering genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
Riemondy, Okay. A. et al. Neoplastic and immune single cell transcriptomics outline subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma. Neuro-oncology 24, 273–286 (2021).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq knowledge with DESeq2. Genome Biol. 15, 550 (2014).
Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation evaluation for microarray and RNA-seq knowledge. BMC Bioinformatics 14, 7 (2013).
Hao, Y. et al. Built-in evaluation of multimodal single-cell knowledge. Cell 184, 3573–3587 (2021).
Korsunsky, I. et al. Quick, delicate and correct integration of single-cell knowledge with Concord. Nat. Strategies 16, 1289–1296 (2019).
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for quick and delicate epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome place. Nat. Strategies 10, 1213–1218 (2013).
Buenrostro, J. D., Wu, B., Chang, H. Y. & Greenleaf, W. J. ATAC-seq: a way for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21.29.21–21.29.29 (2015).
Corces, M. R. et al. An improved ATAC-seq protocol reduces background and allows interrogation of frozen tissues. Nat. Strategies 14, 959–962 (2017).
Li, H. Aligning sequence reads, clone sequences and meeting contigs with BWA-MEM. Preprint at https://arxiv.org/abs/1303.3997 (2013).
Ramírez, F., Dündar, F., Diehl, S., Grüning, B. A. & Manke, T. deepTools: a versatile platform for exploring deep-sequencing knowledge. Nucleic Acids Res. 42, W187–W191 (2014).
Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011).
Vo, B. T. et al. Mouse medulloblastoma pushed by CRISPR activation of mobile Myc. Sci Rep. 8, 8733 (2018).
Lee, C. et al. Lsd1 as a therapeutic goal in Gfi1-activated medulloblastoma. Nat. Commun. 10, 332 (2019).